NCT Number: NCT04860583
Nephrocalcinosis in Very Low Birth Weight Infants
Extremely premature children benefit from specific follow-up that requires high nutritional intake and the use of specific therapies that expose them to the risk of nephrocalcinosis. Other identified risk factors are extreme prematurity and intrauterine growth restriction.
The incidence of nephrocalcinosis in very premature infants is unclear, ranging from 7 to 64%. Most studies are observational and only few case-control studies can properly analyse the risk factors for nephrocalcinosis in significant populations that include only preterm infants.
This nephrocalcinosis of prematurity regresses spontaneously in more than half of the cases, but has been associated with a risk of long-term complications: impaired renal function, high blood pressure, etc. This is an aggravating factor in the context of prematurity, which has been associated with an increased risk of renal impairment and hypertension in childhood and adulthood.
For all these reasons, nutritional intakes and therapeutics are monitored very closely and a renal ultrasound is routinely performed at discharge at 35 weeks of corrected gestational age in all children who are born at a gestational age ≤ 32 weeks and/or birth weight ≤ 1500 g.
Looking for future studies?
Notify MeKey information
Conditions
Sex eligibility
All sexes
Study type
Observational
Who can participate
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
- Newborns with a gestational age <= 32 weeks and/or birthweight <=1500g
Exclusion criteria
- Newborns with kidney malformation
Treatment and study plan
Primary outcomes
-
Prevalence of nephrocalcinosis
Time frame: At week 35 of corrected gestational age
Presence/absence of nephrocalcinosis will be checked by ultrasound
Sponsors and collaborators
Lead sponsor
Hospices Civils de Lyon
Other
Registry information
Official study title
Nephrocalcinosis in Very Low Birth Weight Infants: an Observational Study
Important dates
- Study start
- 2012
- Primary completion
- 2020
- Study completion
- 2020
- First posted
- Apr 27, 2021
- Registry last updated
- Apr 27, 2021
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Related clinical trials
Published trials that share one or more normalized conditions with this study.
Development and Effectiveness Evaluation of a Clustered Care Guideline Within Individualized Developmental Care: RCT
NCT07052786
Clustered Care, Developmental Care
Konya, Turkey (Türkiye)
View Trial DetailsEngaging Mothers & Babies; Reimagining Antenatal Care for Everyone (EMBRACE) Study
NCT04154423
Anxiety Disorders, Behavior
Fresno, California, United States
View Trial DetailsBEP Targeting Strategies in Ethiopia
NCT06125860
Birth Weight, Body Weight
Addis Ababa, Ethiopia
View Trial DetailsHigher-Dose Dexamethasone Improves Breathing and Shortens NICU Stay in Preterm Babies
NCT07765329
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Digestive System Diseases
Medan, North Sumatera, Indonesia
View Trial Details